Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $354,321 | 157 | 89.9% |
| Food and Beverage | $21,640 | 648 | 5.5% |
| Travel and Lodging | $9,805 | 32 | 2.5% |
| Honoraria | $7,100 | 2 | 1.8% |
| Consulting Fee | $968.00 | 3 | 0.2% |
| Education | $224.93 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $320,205 | 331 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $45,033 | 114 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13,017 | 31 | $0 (2020) |
| Lundbeck LLC | $8,339 | 17 | $0 (2018) |
| Amgen Inc. | $1,343 | 79 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $993.03 | 43 | $0 (2019) |
| Amarin Pharma Inc. | $870.68 | 27 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $561.53 | 36 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $410.27 | 28 | $0 (2019) |
| Allergan Inc. | $397.17 | 19 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40,873 | 36 | Janssen Pharmaceuticals, Inc ($40,350) |
| 2023 | $59,918 | 60 | Janssen Pharmaceuticals, Inc ($59,482) |
| 2022 | $55,379 | 70 | Janssen Pharmaceuticals, Inc ($55,032) |
| 2021 | $44,493 | 78 | Janssen Pharmaceuticals, Inc ($44,208) |
| 2020 | $1,860 | 30 | Janssen Pharmaceuticals, Inc ($1,381) |
| 2019 | $64,450 | 146 | Janssen Pharmaceuticals, Inc ($62,513) |
| 2018 | $68,093 | 209 | Janssen Pharmaceuticals, Inc ($33,473) |
| 2017 | $58,994 | 221 | Janssen Pharmaceuticals, Inc ($23,766) |
All Payment Transactions
850 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $130.06 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $545.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/02/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: NEUROLOGY | ||||||
| 09/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,182.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $122.19 | General |
| Category: Cardiology | ||||||
| 08/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiology | ||||||
| 08/15/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/01/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Cardiology | ||||||
| 06/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Cardiology | ||||||
| 05/31/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,182.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/30/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,182.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/22/2024 | Cumberland Pharmaceuticals, Inc. | CALDOLOR (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: ANESTHESIOLOGY PAIN MANAGEMENT | ||||||
| 05/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: Cardiology | ||||||
| 05/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,195.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,182.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,182.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/05/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 13,035 | 18,546 | $15.9M | $1.7M |
| 2022 | 42 | 12,406 | 17,821 | $15.5M | $1.7M |
| 2021 | 46 | 12,279 | 17,522 | $16.8M | $1.8M |
| 2020 | 39 | 9,961 | 14,251 | $13.9M | $1.5M |
All Medicare Procedures & Services
170 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,314 | 2,971 | $1.8M | $332,421 | 18.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 1,506 | 1,602 | $3.1M | $258,056 | 8.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 581 | 582 | $1.1M | $248,412 | 23.1% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 1,054 | 1,061 | $1.9M | $216,753 | 11.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 1,155 | 1,171 | $2.1M | $204,646 | 10.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 582 | 1,164 | $931,200 | $110,838 | 11.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 292 | 1,172 | $902,440 | $51,281 | 5.7% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 1,046 | 1,053 | $1.0M | $51,117 | 5.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 589 | 591 | $413,700 | $34,239 | 8.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,191 | 2,067 | $299,715 | $26,118 | 8.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 1,050 | 1,058 | $1.0M | $23,993 | 2.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 112 | 114 | $88,920 | $17,362 | 19.5% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 106 | 108 | $173,016 | $16,887 | 9.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 88 | 122 | $151,280 | $14,916 | 9.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 58 | 293 | $117,200 | $13,812 | 11.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 945 | 1,580 | $32,744 | $13,233 | 40.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $86,739 | $12,115 | 14.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 121 | $50,820 | $9,893 | 19.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 67 | 132 | $91,080 | $9,093 | 10.0% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 44 | 44 | $73,758 | $7,656 | 10.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 101 | $64,135 | $7,461 | 11.6% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 302 | 341 | $50,809 | $6,869 | 13.5% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 44 | 103 | $49,955 | $4,211 | 8.4% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 303 | 346 | $37,022 | $3,986 | 10.8% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 32 | 35 | $43,127 | $3,808 | 8.8% |
About Dr. Michael Levine, MD
Dr. Michael Levine, MD is a Internal Medicine healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003948464.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Levine, MD has received a total of $394,059 in payments from pharmaceutical and medical device companies, with $40,873 received in 2024. These payments were reported across 850 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($354,321).
As a Medicare-enrolled provider, Levine has provided services to 47,681 Medicare beneficiaries, totaling 68,140 services with total Medicare billing of $6.7M. Data is available for 4 years (2020–2023), covering 170 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location New Hyde Park, NY
- Active Since 03/12/2007
- Last Updated 03/26/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1003948464
Products in Payments
- XARELTO (Drug) $320,205
- Livalo (Drug) $44,853
- PRADAXA (Drug) $12,465
- NORTHERA (Drug) $8,339
- Vascepa (Drug) $870.68
- Corlanor (Drug) $714.72
- Repatha (Biological) $628.58
- JARDIANCE (Drug) $605.69
- PRALUENT (Drug) $599.86
- ENTRESTO (Drug) $561.53
- MULTAQ (Drug) $393.17
- BRILINTA (Drug) $314.87
- ELIQUIS (Drug) $247.82
- XIFAXAN (Drug) $222.20
- BYSTOLIC (Drug) $193.47
- Belviq (Drug) $189.73
- LIVALO (Drug) $180.11
- Veltassa (Drug) $173.83
- INTERSTIM (Device) $166.76
- WATCHMAN FLX (Device) $146.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New Hyde Park
Nikhil Sharma, M.d, M.D
Internal Medicine — Payments: $89,735
Nagashree Seetharamu, Md, MD
Internal Medicine — Payments: $65,767
Dr. Abhinav Agrawal, M.d, M.D
Internal Medicine — Payments: $49,576
Dr. Thomas Mathew, Md, MD
Internal Medicine — Payments: $47,542
Dr. Kennedy Omonuwa, M.d, M.D
Internal Medicine — Payments: $45,556
Lydia Gorski, M.d, M.D
Internal Medicine — Payments: $21,738